3 results match your criteria: "Molinette General Hospital[Affiliation]"

Article Synopsis
  • Lateral flow immunoassays (LFIA) are used for quick testing of infectious diseases like COVID-19, with their accuracy heavily depending on the quality of immunoreagents.
  • Researchers developed two types of LFIA devices using broad-selective bacterial proteins (SpA and SpG) linked to gold nanoparticles to enhance sensitivity and versatility in detecting SARS-CoV-2 antibodies.
  • The SpA-based LFIA showed a higher diagnostic sensitivity (89.9%) and selectivity (91.7%) in testing human serum samples compared to the SpG-based assay and could also detect antibodies in pets of COVID-19 patients.
View Article and Find Full Text PDF

Using specific monoclonal antibodies and the indirect immunofluorescence technique, peripheral blood myeloid leukemic blasts from 49 patients were studied for DR expression, 42 for DQ and nine for DP after four days of culture without and with gamma-IFN. The expression of class II molecules on untreated cells depended upon the stage of differentiation and was maximal for DR antigens and lower for DP, while DQ was present only in a small percentage of M2, M4 or M5 blasts. M3 blasts lacked both DR and DQ.

View Article and Find Full Text PDF